Eli Lilly and Company (NYSE:LLY) Receives $1,002.80 Consensus Price Target from Analysts
Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-one analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eighteen have issued a buy rating on […]
Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-one analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eighteen have issued a buy rating on […]
